{"id":"W1995904050","doi":"10.1086/605431","title":"Use of Peroxisome Proliferator‐Activated Receptor γ Agonists as Adjunctive Treatment for <i>Plasmodium falciparum</i> Malaria: A Randomized, Double‐Blind, Placebo‐Controlled Trial","year":2009,"lang":"en","type":"article","venue":"Clinical Infectious Diseases","topic":"Malaria Research and Control","field":"Medicine","cited_by":72,"is_retracted":false,"has_abstract":true,"ca_institutions":"North York General Hospital; University of Toronto; University Health Network; Toronto General Hospital","funders":"Canada Research Chairs; Canadian Institutes of Health Research; Genome Canada; Ontario Genomics; Ontario Genomics Institute; University of Washington; GlaxoSmithKline","keywords":"Malaria; Medicine; Rosiglitazone; Adjunctive treatment; Plasmodium falciparum; Case fatality rate; Placebo; Immunology; Artemisinin; Peroxisome proliferator-activated receptor; Pharmacology; Internal medicine; Receptor; Epidemiology; Pathology","routes":{"ca_aff":true,"ca_fund":true,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001915873,0.001517369,0.004002369,0.0005586815,0.000612004,0.00109617,0.001101142,0.002452128,0.00567239],"category_scores_gemma":[0.001786342,0.0007811516,0.002364373,0.0006325102,0.001332162,0.0009229506,0.0003603823,0.002607448,0.0007661931],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0005815161,"about_ca_system_score_gemma":0.001321452,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.000809862,"about_ca_topic_score_gemma":0.001405471,"domain_scores_codex":[0.9991768,0.000413816,0.00009246691,0.0001495591,0.00006797242,0.00009941238],"domain_scores_gemma":[0.998852,0.0003467993,0.0003234228,0.00007350378,0.000103796,0.0003004882],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","study_design_scores_codex":[0.9842115,0.004102739,0.0002766419,0.001143802,0.0009023345,0.00002230979,0.00002194732,0.00007349992,0.001567568,0.0000360901,0.0003186085,0.007322912],"study_design_scores_gemma":[0.9705079,0.02787053,0.0005448912,0.00004570219,0.0005068337,0.0000115886,0.000007182503,0.00008813731,0.000164042,0.00002552636,0.0002216501,0.000006007935],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9607382,0.02188444,0.001152195,0.001386693,0.001602527,0.009544214,0.001216523,0.0002197042,0.002255518],"genre_scores_gemma":[0.9663871,0.01419657,0.002584161,0.002261394,0.001601991,0.009546291,0.001050991,0.00003220035,0.00233927],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.00567239,"threshold_uncertainty_score":0.01897603,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.06846260567833032,"score_gpt":0.3812203698655188,"score_spread":0.3127577641871885,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}